8-KThe WireStrategic
Material Agreement · New Debt / Obligation
Filed Jun 25, 2026 · 8d ago · Accession 0001193125-26-282990
Plain English
Ligand Pharmaceuticals Incorporated completed a private offering of $700.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031. This offering included the exercise of an option for an additional $75.0 million aggregate principal amount of Notes.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- 8-K
- Filing date
- Jun 25, 2026
- Report date
- Jun 25, 2026
- Document
- d167360d8k.htm
- Size
- 1.5 MB